Evidence map›Paper›PMID 27579475›Full record

ArticleMolecular medicine (Cambridge, Mass.)2016

Cadherin 13: human

Jana Drgonova, Donna Walther, G Luke Hartstein, Mohammad O Bukhari, Michael H Baumann, Jonathan Katz, Frank Scott Hall, Elizabeth R Arnold, Shaun Flax, Anthony Riley and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Association of theAmerican journal of translational research · 2023
    Article
  8. Review
  9. A CommonGenes · 2021
    Article
  10. Article
  11. Genetics of ADHD: What Should the Clinician Know?Current psychiatry reports · 2020
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Jana DrgonovaMolecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Donna WaltherMolecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
G Luke HartsteinMolecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Mohammad O BukhariMedicinal Chemistry, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Michael H BaumannMedicinal Chemistry, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Jonathan KatzMedicinal Chemistry, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Frank Scott HallMolecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Elizabeth R ArnoldMolecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
Shaun FlaxDept of Psychology, American Univ, Washington, DC.
Anthony RileyDept of Psychology, American Univ, Washington, DC.
Olga Rivero-MartinTranslational Neurobiology, Dept Psychiatry, Univ Würzburg, Würzburg Germany.
Klaus-Peter LeschTranslational Neurobiology, Dept Psychiatry, Univ Würzburg, Würzburg Germany.
Juan TroncosoDiv Neuropathology, Johns Hopkins Sch Med, Baltimore MD 21202.
Barbara RanschtSanford-Burnham Med Res Inst, La Jolla CA 92037.
George R UhlMolecular Neurobiology, NIH-IRP, NIDA, Baltimore, Maryland 21224.
National Institute on Drug Abuse · USAmerican University · USUniversity of Würzburg · DEJohns Hopkins University · USNew Mexico VA Health Care System · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Preclinical medication development for stimulant use disorderZIADA000522 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$8.9M
Basic Dopamine Transporter Mechanisms Of CocaineZIADA000103 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KATZ, JONATHAN L · 2009 to 2016
$4.6M
Role of T-Cadherin in Adiponection-mediated cardiovascular functionsR21HL102680 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RANSCHT, BARBARA · 2010 to 2011
$525k
NHLBI NIH HHS R21 HL102680
6 · The paper itself

Abstract

The cadherin 13 (CDH13) gene encodes a cell adhesion molecule likely to influence development and connections of brain circuits that modulate addiction, locomotion and cognition, including those that involve midbrain dopamine neurons. Human CDH13 mRNA expression differs by more than 80% in postmortem cerebral cortical samples from individuals with different CDH13 genotypes, supporting examination of mice with altered Cdh13 expression as models for common human variation at this locus. Constitutive cdh13 knockout mice display evidence for changed cocaine reward: shifted dose response relationship in tests of cocaine-conditioned place preference using doses that do not alter cocaine conditioned taste aversion. Reduced adult Cdh13 expression in conditional knockouts also alters cocaine reward in ways that correlate with individual differences in cortical Cdh13 mRNA levels. In control and comparison behavioral assessments, knockout mice display modestly-quicker acquisition of rotarod and water maze tasks, with a trend toward faster acquisition of 5 choice serial reaction time tasks that otherwise displayed no genotype-related differences. They display significant differences in locomotion in some settings, with larger effects in males. In assessments of brain changes that might contribute to these behavioral differences, there are selective alterations of dopamine levels, dopamine/metabolite ratios, dopaminergic fiber densities and mRNA encoding the activity dependent transcription factor

Indexed as

addictionattention deficit hyperactivity disordercell adhesion moleculecocaineconditioned place preference

Identifiers

PMID27579475
PMCPMC5082297
OpenAlexW2510175995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.